138 related articles for article (PubMed ID: 29929887)
1. Gene Expression Signatures Predicting Survival and Chemotherapy Benefit in Patients with Resected Non-small-Cell Lung Cancer.
Rosell R; Karachaliou N
EBioMedicine; 2018 Jul; 33():16-17. PubMed ID: 29929887
[No Abstract] [Full Text] [Related]
2. Predicting response to chemotherapy with early-stage lung cancer.
Rosell R; Taron M; Massuti B; Mederos N; Magri I; Santarpia M; Sanchez JM
Cancer J; 2011; 17(1):49-56. PubMed ID: 21263267
[TBL] [Abstract][Full Text] [Related]
3. Cell cycle regulators and outcome of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer: the International Adjuvant Lung Cancer Trial Biologic Program.
Filipits M; Pirker R; Dunant A; Lantuejoul S; Schmid K; Huynh A; Haddad V; André F; Stahel R; Pignon JP; Soria JC; Popper HH; Le Chevalier T; Brambilla E
J Clin Oncol; 2007 Jul; 25(19):2735-40. PubMed ID: 17602078
[TBL] [Abstract][Full Text] [Related]
4. The role of adjuvant chemotherapy in early-stage and locally advanced non-small cell lung cancer.
Shapiro M
Cleve Clin J Med; 2012 May; 79 Electronic Suppl 1():eS42-5. PubMed ID: 22614965
[TBL] [Abstract][Full Text] [Related]
5. The coming of age of molecular tumor profiling.
Antonoff MB; D'Cunha J
Semin Thorac Cardiovasc Surg; 2011; 23(1):8-9. PubMed ID: 21807290
[TBL] [Abstract][Full Text] [Related]
6. Molecular prediction of adjuvant cisplatin efficacy in Non-Small Cell Lung Cancer (NSCLC)-validation in two independent cohorts.
Buhl IK; Santoni-Rugiu E; Ravn J; Hansen A; Christensen IJ; Jensen T; Pratt B; Askaa J; Jensen PB; Knudsen S; Sørensen JB
PLoS One; 2018; 13(3):e0194609. PubMed ID: 29566065
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant chemotherapy for surgically resected non-small cell lung cancer.
Heon S; Johnson BE
J Thorac Cardiovasc Surg; 2012 Sep; 144(3):S39-42. PubMed ID: 22502967
[TBL] [Abstract][Full Text] [Related]
8. Randomised study of adjuvant chemotherapy for completely resected p-stage I-IIIA non-small cell lung cancer.
Nakagawa K; Tada H; Akashi A; Yasumitsu T; Iuchi K; Taki T; Kodama K;
Br J Cancer; 2006 Oct; 95(7):817-21. PubMed ID: 16969350
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant chemotherapy for resected non-small-cell lung cancer--ANITA takes the stage.
Azzoli CG
Lancet Oncol; 2006 Sep; 7(9):701-3. PubMed ID: 16945762
[No Abstract] [Full Text] [Related]
10. Referral patterns for adjuvant chemotherapy in patients with completely resected non-small cell lung cancer.
Kassam F; Shepherd FA; Johnston M; Visbal A; Feld R; Darling G; Keshavjee S; Pierre A; Waddell T; Leighl NB
J Thorac Oncol; 2007 Jan; 2(1):39-43. PubMed ID: 17410008
[TBL] [Abstract][Full Text] [Related]
11. Can adjuvant chemotherapy improve survival in patients with early-stage, resected non-small-cell lung cancer?
Azzoli CG
Nat Clin Pract Oncol; 2005 Nov; 2(11):552-3. PubMed ID: 16270095
[No Abstract] [Full Text] [Related]
12. [Adjuvant chemotherapy for non-small cell lung cancer].
Okamoto T; Ichinose Y
Gan To Kagaku Ryoho; 2006 Dec; 33(13):1985-90. PubMed ID: 17197740
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemotherapy for completely resected non-small-cell lung cancer.
Suehisa H; Toyooka S
Acta Med Okayama; 2009 Oct; 63(5):223-30. PubMed ID: 19893597
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant chemotherapy after pulmonary resection for lung cancer.
Mascaux C; Shepherd FA
Thorac Surg Clin; 2013 Aug; 23(3):401-10. PubMed ID: 23931022
[TBL] [Abstract][Full Text] [Related]
15. [Predicting efficacy of neoadjuvant cheomotherapy on resectable stage IIIA non-small cell lung cancer by multi-gene expressions].
Cheng C; Wu YL; Gu LJ; Chen G; Weng YM; Feng WN; Zhong WZ
Ai Zheng; 2005 Jul; 24(7):846-9. PubMed ID: 16004813
[TBL] [Abstract][Full Text] [Related]
16. Current status of adjuvant chemotherapy in NSCLC.
Scagliotti GV; Novello S
Ann Oncol; 2006 May; 17 Suppl 5():v62-3. PubMed ID: 16807465
[No Abstract] [Full Text] [Related]
17. Predictive Significance of Thymidylate Synthase Expression in Non-small Cell Lung Cancer.
Kulda V; Hrda K; Houdek Z; Dobra JK; Vrzakova R; Svaton M; Safranek J; Dolezal J; Babuska V; Pesek M; Topolcan O; Pesta M
Anticancer Res; 2017 Dec; 37(12):6953-6958. PubMed ID: 29187479
[TBL] [Abstract][Full Text] [Related]
18. Multidrug resistance proteins do not predict benefit of adjuvant chemotherapy in patients with completely resected non-small cell lung cancer: International Adjuvant Lung Cancer Trial Biologic Program.
Filipits M; Haddad V; Schmid K; Huynh A; Dunant A; André F; Brambilla E; Stahel R; Pignon JP; Soria JC; Popper HH; Le Chevalier T; Pirker R
Clin Cancer Res; 2007 Jul; 13(13):3892-8. PubMed ID: 17606722
[TBL] [Abstract][Full Text] [Related]
19. [Early stages of non small cell lung cancer (I. II. IIIA). Postoperative treatments for resected non small-cell lung cancer].
Barlési F
Rev Mal Respir; 2006 Nov; 23(5 Pt 3):16S47-16S53. PubMed ID: 17268336
[TBL] [Abstract][Full Text] [Related]
20. Postoperative Adjuvant Systemic Therapy in Completely Resected Non-Small-Cell Lung Cancer: A Systematic Review.
Bradbury P; Sivajohanathan D; Chan A; Kulkarni S; Ung Y; Ellis PM
Clin Lung Cancer; 2017 May; 18(3):259-273.e8. PubMed ID: 28162945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
